Prenatally detected fragile X females: long-term follow-up studies show high risk of mental impairment
- PMID: 1605241
- DOI: 10.1002/ajmg.1320430114
Prenatally detected fragile X females: long-term follow-up studies show high risk of mental impairment
Abstract
The prenatal detection of a positive fragile X [fra(X)] female raises difficult counseling issues. In order to address questions regarding the long term outlook, we have conducted follow-up studies on 4 fra(X) positive females which were carried to term. Three were prenatally detected, and one was a false negative. The subjects were between 3 and 7 years old when follow-up investigation of mental status was conducted. The first case age, 6 and 9/12 years, had an IQ of 106. On measures of achievement she had some difficulty with arithmetic. The second and third cases were clearly affected. They were judged to be mildly to moderately mentally retarded. The fourth case was borderline normal. The prenatal amniocentesis cytogenetic frequencies had a mean of 3.74% (range 0-8.5%). On postnatal follow-up testing of blood, the mean cytogenetic frequency increased to 31.75% (range 24-47%), an 8.5 fold increase. Follow-up DNA samples from 3 of the 4 subjects were analyzed for underlying DNA mutations using probe StB12.3 which detects insertions and methylation status of the FMR-1 gene. All 3 showed an affected female genotype with a large insert (greater than 500bp) and complete CpG island methylation. We conclude: (1) prenatally detected cytogenetic frequencies of females increase by an average 8.5 fold on follow-up postnatal studies, (2) genetic counseling should indicate the risks to be affected are approximately 75% when a positive female is prenatally detected, (3) DNA testing can help determine carrier status but may not accurately predict whether a female will be mentally affected.
Similar articles
-
Mental impairment in cytogenetically positive fragile X females.Am J Med Genet. 1991 Feb-Mar;38(2-3):503-4. doi: 10.1002/ajmg.1320380272. Am J Med Genet. 1991. PMID: 2018094
-
Prenatal diagnosis of fragile X syndrome: results from parallel molecular and cytogenetic studies.Am J Med Genet. 1992 Apr 15-May 1;43(1-2):181-6. doi: 10.1002/ajmg.1320430130. Am J Med Genet. 1992. PMID: 1605190
-
An assessment of the use of flanking DNA markers for fra(X) syndrome carrier detection and prenatal diagnosis.Am J Med Genet. 1986 Jan-Feb;23(1-2):665-83. doi: 10.1002/ajmg.1320230159. Am J Med Genet. 1986. PMID: 3006491
-
The fragile X syndrome: implications of molecular genetics for the clinical syndrome.Eur J Clin Invest. 1994 Jan;24(1):1-10. doi: 10.1111/j.1365-2362.1994.tb02052.x. Eur J Clin Invest. 1994. PMID: 8187801 Review.
-
[Fragile X syndrome: current knowledge].Pediatrie. 1992;47(11):743-50. Pediatrie. 1992. PMID: 1364151 Review. French.
Cited by
-
GC-rich repeat expansions: associated disorders and mechanisms.Med Genet. 2022 Jan 12;33(4):325-335. doi: 10.1515/medgen-2021-2099. eCollection 2021 Dec. Med Genet. 2022. PMID: 38835438 Free PMC article.
-
Molecular carrier testing for the fragile X syndrome: Issues for genetic counselors.J Genet Couns. 1994 Sep;3(3):233-44. doi: 10.1007/BF01412229. J Genet Couns. 1994. PMID: 24234009
-
Polymerase chain reaction analysis of fragile X mutations.Hum Genet. 1992 Sep-Oct;90(1-2):55-61. doi: 10.1007/BF00210744. Hum Genet. 1992. PMID: 1427787
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical